- Home
- MAIA vs RPID Comparison
MAIA vs RPID Comparison
Compare MAIA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- RPID
- Stock Information
- Founded
- MAIA 2018
- RPID 2006
- Country
- MAIA United States
- RPID United States
- Employees
- MAIA N/A
- RPID N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- MAIA Health Care
- RPID Health Care
- Exchange
- MAIA Nasdaq
- RPID Nasdaq
- Market Cap
- MAIA 52.8M
- RPID 43.5M
- IPO Year
- MAIA 2022
- RPID 2021
- Fundamental
- Price
- MAIA $2.00
- RPID $1.23
- Analyst Decision
- MAIA
- RPID
- Analyst Count
- MAIA 0
- RPID 0
- Target Price
- MAIA N/A
- RPID N/A
- AVG Volume (30 Days)
- MAIA 346.7K
- RPID 144.4K
- Earning Date
- MAIA 11-12-2024
- RPID 02-28-2025
- Dividend Yield
- MAIA N/A
- RPID N/A
- EPS Growth
- MAIA N/A
- RPID N/A
- EPS
- MAIA N/A
- RPID N/A
- Revenue
- MAIA N/A
- RPID $26,170,000.00
- Revenue This Year
- MAIA N/A
- RPID $24.34
- Revenue Next Year
- MAIA N/A
- RPID $19.49
- P/E Ratio
- MAIA N/A
- RPID N/A
- Revenue Growth
- MAIA N/A
- RPID 27.31
- 52 Week Low
- MAIA $1.17
- RPID $0.58
- 52 Week High
- MAIA $5.99
- RPID $1.45
- Technical
- Relative Strength Index (RSI)
- MAIA 44.72
- RPID 65.59
- Support Level
- MAIA $1.97
- RPID $1.00
- Resistance Level
- MAIA $2.44
- RPID $1.37
- Average True Range (ATR)
- MAIA 0.20
- RPID 0.12
- MACD
- MAIA 0.00
- RPID 0.03
- Stochastic Oscillator
- MAIA 8.33
- RPID 62.07
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.